Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab.
This report contains market size and forecasts of Ranibizumab in Global, including the following market information:
Global Ranibizumab Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Ranibizumab market was valued at 3549.5 million in 2021 and is projected to reach US$ 1768.3 million by 2028, at a CAGR of -9.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Glass Vial Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Ranibizumab include Roche and Novartis etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Ranibizumab companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ranibizumab Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Ranibizumab Market Segment Percentages, by Type, 2021 (%)
Glass Vial
Prefilled Syringe
Global Ranibizumab Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Ranibizumab Market Segment Percentages, by Application, 2021 (%)
Wet AMD
Complications of Diabetes
RVO
Others
Global Ranibizumab Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Ranibizumab Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ranibizumab revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Ranibizumab revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Novartis

LEAVE A REPLY

Please enter your comment!
Please enter your name here